Target intelligence / Profile preview

GTP binding elongation factor GUF1 (GUF1)

Target
GUF1
Molecular classification
Enzyme (specifically, GTPase), Mitochondrial translation factor, Ribosomal back-translocase
01

Overview

GTP binding elongation factor GUF1 (GUF1) is a highly conserved mitochondrial GTPase that acts as a fidelity factor during mitochondrial protein synthesis[1][5][6]. GUF1 binds to mitochondrial ribosomes in a GTP-dependent manner and catalyzes the backward translocation of tRNAs on the ribosome, helping to prevent amino acid misincorporation, especially under stressful or suboptimal conditions[1][4][5]. It possesses unique C-terminal domains crucial for tRNA interaction, which distinguishes it from other GTPases[1]. The gene is most highly expressed in the brain, with lower expression in the pancreas, and alternative splicing yields several transcript variants[1]. Mutations in GUF1 are associated with developmental and epileptic encephalopathy 40 (EIEE40), a severe neurodevelopmental disorder, implicating its essential role in mitochondrial function and neuronal health[5]. While not currently an established therapeutic target, GUF1 dysfunction is linked to neurological and possibly metabolic diseases[2][1][5].

Other names
Translation factor GUF1, mitochondrialEF-4EF4GUF1 homologGTPase GUF1Ribosomal back-translocaseDEE40EIEE40GTP-binding protein GUF1 homologGTPase of unknown function 1
02

Biological functions

Mitochondrial translation elongationFidelity control of mitochondrial protein synthesisRibosomal back-translocation to prevent amino acid misincorporationRegulation of mitochondrial gene expression
03

Disease associations

Neurodevelopmental disease (notably developmental and epileptic encephalopathy 40)Possible role in mitochondrial diseasesPotential involvement in cancer by dysregulation of mitochondrial translation

Beyond the preview

Go deeper on GTP binding elongation factor GUF1 (GUF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GTP binding elongation factor GUF1 (GUF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call